|
Real-time Estimate
Cboe Europe
02:33:57 27/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 17.95 SEK | +4.12% |
|
+6.38% | -20.27% |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 97.25M | - | - | - | - | - |
| 1,135B | |||||
| 635B | |||||
| 505B | |||||
| 378B | |||||
| 358B |
- Stock Market
- Stocks
- SYNACT Stock
- Charts SynAct Pharma AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
